Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Colonic Neoplasms × tislelizumab × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 7 Esophageal Squamous Cell Carcinoma 4 Carcinoma, Hepatocellular 4 Advanced Solid Tumors 4 Recurrence 3 Neoplasm Metastasis 3 Stomach Neoplasms 2 Small Cell Lung Carcinoma 2 Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Colorectal Neoplasms 2 Uterine Cervical Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Solid Tumors 1 Sarcoma 1 Neuroendocrine Tumors 1 Nasopharyngeal Neoplasms 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Lung Neoplasms 1 Locally Advanced or Metastatic Urothelial Bladder Cancer 1 Locally Advanced and Metastatic Solid Tumors 1 Limited Stage Small Cell Lung Cancer 1

Interventions

Leucovorin 35 Fluorouracil 33 Oxaliplatin 31 Bevacizumab 29 Irinotecan 28 Cetuximab 21 Capecitabine 16 Panitumumab 13 IFL protocol 6 Folfox protocol 6 Nivolumab 5 Immunohistochemistry 5 pembrolizumab 4 Ramucirumab 4 Radiotherapy 4 Gene Expression Profiling 4 Floxuridine 4 dehydroftorafur 3 aflibercept 3 Surgical Procedures, Operative 3 Radiosurgery 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 Gemcitabine 3 Fluorodeoxyglucose F18 3 Fentanyl 3 Drug Therapy 3 Chemotherapy, Adjuvant 3 Celecoxib 3 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡